- Cochlear Introduces the Baha® 7 Sound Processor and Baha SoundBand™
- Rad AI Names Demetri Giannikopoulos as Chief Growth Officer to Accelerate AI-Driven Radiology Healthcare Growth
- RapidRatings Appoints Charlie Minutella as CEO to Accelerate Strategic Growth and Innovation
- Dr Ray Kotwicki, Chief Medical Officer of Hightop Health, Appointed President of the Southern Psychiatric Association
- Terumo Neuro Announces EMEA Commercial Availability of the SOFIA Flow 88 Neurovascular Aspiration Catheter
- FDA Grants De Novo Clearance for Reflow Medical’s Spur® Peripheral Retrievable Stent System
- GC Biopharma’s Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation
Jeremiah Robison, CIONIC Founder & CEO. “We are proud to work with IMSMP, Jersey Shore University Medical Center, and MedStar Health to deliver a unified care experience with the Neural Sleeve from the clinic to the home, setting a new standard for mobility care.”
IQAir Introduces New XE Smart Air Purifiers
Designed and made in Switzerland, the XE line also includes an advanced particle sensor that measures harmful fine particulate pollutants (PM2.5), for real-time insight of indoor air. PM2.5 includes a wide range of pollutants, including smoke, dust, pollen, mold spores, house dust mites, and pet allergens.
B. Braun Launches ACCEL®: Pioneering Interventional Systems
The ACCEL All-Purpose and Biliary Drainage Catheters are designed for optimal patient comfort and clinical care. The catheter features large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating helps with a smooth catheter insertion.
MiRus Siegel ™ TAVR: First in Human Results Presented at New York Valves
radeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel ™ 8-Fr aortic transcatheter heart valve (THV) at the New York Valves conference.
Clinical Trials
SpineX Announces Successful in-Human Results to Treat Adults with Cerebral Palsy
SpineX notes the study affirms how after just eight weeks of SCiP therapy treatment, a 60-year-old woman living with CP is able to perform daily living activities with minimal external assistance.
ChemDiv Marks a Milestone as Orionis Biosciences’ Novel Immunotherapy Enters Phase I Clinical Trials
ChemDiv CEO, Bill Farley. “This marks a significant step in harnessing intrinsic immunobiology pharmacologically, and we are excited about the potential impact it may have on revolutionizing cancer therapeutics.”
AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System | Reports Boston Scientific as First-Line Treatment for Persistent Atrial Fibrillation
The AVANT GUARD clinical trial will evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation System as a first-line treatment for persistent atrial fibrillation, the only trial to study the use of PFA as frontline therapy in patients with this form of AF.
Biotechnology News
The Vital Role of CDMOs in Bringing New Therapies to Market
The relationship between pharmaceutical companies and CDMOs is fundamentally collaborative, fostering an environment of innovation. By partnering with a CDMO, pharmaceutical firms can access a wide array of technologies and expertise that might otherwise be beyond their reach.
Revolutionary T-Cell Analysis Unveiled for Early Cancer Detection at AACR | Reports Serum Detect
Serum Detect is developing diagnostic tests, using standard liquid biopsy samples, that complement and enhance existing screening techniques for early detection of cancer.
Bio-Rad Launches Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
The company announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumor heterogeneity and disease progression at various stages.
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
NICO Raises $12.5 Million in Oversubscribed Investment Round
NICO is an Indianapolis-based medical device innovator creating a new reality in neurosurgery through its MIS technologies. The company has a strong shareholder base that has invested more than $62 million since its inception in 2007.
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
Cresilon advises the financing will support the company’s efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
Monteris Medical notes the proceeds of this financing will be used to continue to support the rapid adoption of the NeuroBlate® System, an MR-guided laser ablation system that allows for a minimally invasive surgical alternative to open craniotomies.
FineHeart Awarded €2.5 Mil Grant by the EC Under the Highly Selective EIC Accelerator Program
FineHeart notes this grant has the potential to be followed by an equity investment of up to €15 million by the EIC Fund at the company’s next series C funding round. It will support the industrialization and clinical trials of the ICOMS FLOWMAKER®.
Market Reports
Advancements in Imaging
Esaote North America installs the first Magnifico™ Open MRI system in Tennessee
Esaote North America notes the Magnifico™ Open offers versatility in imaging across a wide range of clinical applications.
Qmetrics Technologies and 20/15 Visioneers Announce Go-to-Market Partnership
“Concussions are largely diagnosed and managed via patient symptoms,” says Edward Schreyer, CEO, Qmetrics Technologies. “Post-concussive brain injuries are typically too subtle to be seen by the human eye. Our technology-driven Concussion Index uses algorithms to identify post-concussive injuries.
KA Imaging Unveils New Brand Identify for its Patented Dual Energy Technology
KA Imaging’s SpectralDR™ technology enables dual-energy subtraction, providing bone and tissue differentiation with a single standard X-ray exposure.
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
Email Marketing Best Practices: Building Effective Campaigns for Customer Engagement
Email marketing remains a highly effective strategy for engaging customers, nurturing leads, and driving conversions. However, with inboxes flooded with promotional messages, it’s essential to
How Custom Software Development is Revolutionizing the Healthcare Industry
Here, in this article, we explore the groundbreaking changes introduced by custom software development in the healthcare industry, and how it sets the path for future innovations.
Patient Confidentiality and Digital Transformation: Balancing the Scale in Healthcare Facilities
The digitization of healthcare has significantly changed the landscape of this industry, marking a paradigm shift in how medical professionals deliver services to their patients.
Advances in Rheumatology Research: New Discoveries and Treatment Options
Rheumatology is a medical specialty for diagnosing, treating, and preventing rheumatic diseases. In recent years, there have been tremendous advancements in the research of rheumatologic